Restart Life Sciences Corp.
HEAL
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 118.10K | 185.50K | 8.80K | 16.10K | 6.10K |
| Total Receivables | 7.90K | 4.20K | 3.00K | 5.50K | 5.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 3.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 126.00K | 189.70K | 11.80K | 21.60K | 14.90K |
|
|
|||||
| Total Current Assets | 126.00K | 189.70K | 11.80K | 21.60K | 14.90K |
| Net Property, Plant & Equipment | 6.30K | 7.10K | 7.50K | 8.00K | 8.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 132.30K | 196.80K | 19.30K | 29.60K | 23.50K |
|
|
|||||
| Total Accounts Payable | 134.90K | 199.80K | 443.10K | 443.40K | 292.90K |
| Total Accrued Expenses | 146.90K | 386.40K | 296.30K | 247.10K | 344.40K |
| Short-term Debt | 58.30K | 44.40K | 43.80K | 44.30K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 340.20K | 630.60K | 783.20K | 734.90K | 637.30K |
|
|
|||||
| Total Current Liabilities | 340.20K | 630.60K | 783.20K | 734.90K | 637.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 58.30K | 44.40K | 43.80K | 44.30K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 340.20K | 630.60K | 783.20K | 734.90K | 637.30K |
|
|
|||||
| Common Stock & APIC | 35.11M | 37.20M | 36.72M | 37.12M | 38.01M |
| Retained Earnings | -41.05M | -43.72M | -43.49M | -43.89M | -44.89M |
| Treasury Stock & Other | 5.73M | 6.08M | 6.00M | 6.07M | 6.27M |
| Total Common Equity | -207.90K | -433.80K | -763.90K | -705.20K | -613.80K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -207.90K | -433.80K | -763.90K | -705.20K | -613.80K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -207.90K | -433.80K | -763.90K | -705.20K | -613.80K |
|
|
|||||